Literature DB >> 1566345

Assessment of the quality of life before and following liver transplantation. First results.

G J Bonsel1, M L Essink-Bot, I J Klompmaker, M J Slooff.   

Abstract

Analysis of quality-of-life effects is part of the current technology assessment of the Dutch orthotopic liver transplant-program. Data are collected by means of computer-assisted interviewing, including one interview before transplantation and annual follow-up interviews. Data on psychiatric morbidity are obtained from medical records. This article shows preliminary results of a cross-sectional analysis of data collected from 1987 to 1989. Eighty-eight measurements were obtained from 46 adult patients (response rate 82%). Pretransplant scores suggest major restrictions on all domains of life, especially a low amount of energy. After transplantation all indicators show improvement, although the level of the general population is not always attained. Improvement of subjective quality of life is more marked, possibly due to euphoria at surviving the hazardous procedure. Psychiatric events occurred only infrequently. We conclude that orthotopic liver transplantation contributes positively to the quality of life of surviving patients. In addition, computer-assisted interviewing proved to be a feasible survey technique, even when very ill patients were involved.

Entities:  

Mesh:

Year:  1992        PMID: 1566345     DOI: 10.1097/00007890-199204000-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  [Changes in the quality of life after organ transplantations].

Authors:  M Niechzial; T Grobe; H Dörning; H Raspe; E Nagel
Journal:  Soz Praventivmed       Date:  1999

2.  Prevalence and predictors of sleep disturbance among liver diseases in long-term transplant survivors.

Authors:  Mamatha Bhat; Jonathan M Wyse; Erica Moodie; Peter Ghali; Nir Hilzenrat; Philip Wong; Marc Deschenes
Journal:  Can J Gastroenterol Hepatol       Date:  2015-07-15

3.  Coverage of genetic technologies under national health reform.

Authors:  M J Mehlman; J R Botkin; A Scarrow; A Woodhall; J Kass; E Siebenschuh
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

4.  Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.

Authors:  C A Uyl-de Groot; E Vellenga; E G de Vries; B Löwenberg; G J Stoter; F F Rutten
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

5.  Health-related quality of life following liver transplantation.

Authors:  S Bryan; J Ratcliffe; J M Neuberger; A K Burroughs; B K Gunson; M J Buxton
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

6.  Depression in patients with cirrhosis. Impact on outcome.

Authors:  N Singh; T Gayowski; M M Wagener; I R Marino
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 7.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.